Literature DB >> 11291110

Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

M Malatesta1, F Mannello, M Sebastiani, G Gazzanelli.   

Abstract

Gross cystic breast disease (GCBD) is the most common benign disease of the human female breast, and patients with GCBD have an increased risk of breast cancer. The aim of this study was to evaluate the distribution inside apocrine cells and in breast cyst fluids aspirated from gross cysts of prostate-specific antigen (PSA) molecular forms, and to correlate the different intracystic PSA profiles to the subpopulations of gross cysts. Type I cysts showed a median value of 0.71 microg/L of total PSA and 0.32 g/L of ACT, significantly different to that of Type II cysts (Wilcoxon P < 0.001). Although large excesses of ACT were detected in all samples, BCF samples and apocrine cells from Type I gross cysts contained about 70% of free PSA, compared to the higher amounts of complexed PSA found in Type II gross cysts. We demonstrate that in apocrine/secretive Type I breast gross cysts the serine protease PSA was mainly present in its free form, in contrast to a major proportion of complexed PSA found in flattened/transudative Type II cysts. Our results are consistent with the notion that a prolonged exposure of apocrine breast cells lining the Type I gross cysts to the proteolytic activity of PSA could be involved in the etiopathogenesis of GCBD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291110      PMCID: PMC6807965          DOI: 10.1002/jcla.6

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  40 in total

1.  Prostate-specific antigen found in type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Bianchi; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1999-09       Impact factor: 4.872

Review 2.  New biological functions of prostate-specific antigen?

Authors:  E P Diamandis; H Yu
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

3.  Nonprostatic sources of prostate-specific antigen: a steroid hormone-dependent phenomenon?

Authors:  H C Graves
Journal:  Clin Chem       Date:  1995-01       Impact factor: 8.327

4.  Immunohistochemical labelling for prostate-specific antigen in breast carcinomas.

Authors:  K A Alanen; T Kuopio; Y U Collan; P Kronqvist; L Juntti; T J Nevalainen
Journal:  Breast Cancer Res Treat       Date:  1999-07       Impact factor: 4.872

5.  Proteases in cyst fluid from human gross cyst breast disease.

Authors:  L Kesner; W S Yu; H L Bradlow; C W Breed; M Fleisher
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

Review 6.  Prostate-specific antigen expression in a case of intracystic carcinoma of the breast: characterization of immunoreactive protein and literature surveys.

Authors:  F Mannello; M Sebastiani; S Amati; G Gazzanelli
Journal:  Clin Chem       Date:  1997-08       Impact factor: 8.327

7.  Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors.

Authors:  C S Killian; D A Corral; E Kawinski; R I Constantine
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

8.  The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.

Authors:  J M Dixon; A B Lumsden; W R Miller
Journal:  Eur J Cancer Clin Oncol       Date:  1985-09

9.  Prostate specific antigen--a new constituent of breast cyst fluid.

Authors:  E P Diamandis; H Yu; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

Authors:  N J Bundred; R R West; J O Dowd; R E Mansel; L E Hughes
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  1 in total

Review 1.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.